What does Dr. Patrick Braeckman do?

Dr. Patrick Braeckman is a specialist medical practice in Roeselare. Private Limited, started on 11 July 2005, 1 establishment.

What is the address of Dr. Patrick Braeckman?

The registered office of Dr. Patrick Braeckman is located at Tasscheweg 13, 8800 Roeselare.

Is Dr. Patrick Braeckman still active?

Yes. According to the CBE (29 September 2026) Dr. Patrick Braeckman is active, legal situation “Normale toestand”, started on 11 July 2005.

Is Dr. Patrick Braeckman registered on Peppol?

Yes, Dr. Patrick Braeckman is registered on the Peppol network with ID 0208:0874988203.

What is the enterprise number of Dr. Patrick Braeckman?

The enterprise number of Dr. Patrick Braeckman is BE0874988203.

When was Dr. Patrick Braeckman founded?

Dr. Patrick Braeckman was founded on 11 July 2005.

Who are the directors of Dr. Patrick Braeckman?

According to the 2025 annual accounts, the directors of Dr. Patrick Braeckman are: Patrick Braeckman.

Is Dr. Patrick Braeckman a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 July 2005; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Patrick Braeckman make in 2025?

Dr. Patrick Braeckman posted a profit after taxes of € 156,627 in financial year 2025.

What is the revenue of Dr. Patrick Braeckman?

As a small company, Dr. Patrick Braeckman is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 220,890.

Dr. Patrick Braeckman (Private Limited) - Roeselare

Dossier Dr. Patrick Braeckman, printed on 29 September 2026 from databakkes.be/en/0874988203/dr-patrick-braeckman. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Patrick Braeckman from Roeselare, company number BE0874988203, closed financial year 2025 with a result of € 156,627 after tax. For that financial year Dr. Patrick Braeckman recorded a gross margin of € 220,890 and equity of € 12,400. Compared with financial year 2024, the result moved from € 132,948 to € 156,627. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on February 2, 2026.

What it is worth Healthy

€ 12,400

▼ 35% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 156,627

▲ 18% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 148,915

▲ 8% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 163,266 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 29,155

▼ 27% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 29,092

▼ 26% vs 2024

€ 10,895 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 2,390

▲ 93% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,287

▼ 46% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 188,192 Gross margin 2022: € 188,192 First fiscal year in the series	€ 164,873 Gross margin 2023: € 164,873 ▼ 12% vs 2022 (€ 188,192) Unfavourable step	€ 187,069 Gross margin 2024: € 187,069 ▲ 13% vs 2023 (€ 164,873) Favourable step	€ 220,890 Gross margin 2025: € 220,890 ▲ 18% vs 2024 (€ 187,069) Favourable step	▲ 18%
Profit after taxes	€ 135,633 Profit after taxes 2022: € 135,633 First fiscal year in the series	€ 119,780 Profit after taxes 2023: € 119,780 ▼ 12% vs 2022 (€ 135,633) Unfavourable step	€ 132,948 Profit after taxes 2024: € 132,948 ▲ 11% vs 2023 (€ 119,780) Favourable step	€ 156,627 Profit after taxes 2025: € 156,627 ▲ 18% vs 2024 (€ 132,948) Favourable step	▲ 18%
Equity	€ 23,266 Equity 2022: € 23,266 First fiscal year in the series	€ 21,091 Equity 2023: € 21,091 ▼ 9% vs 2022 (€ 23,266) Unfavourable step	€ 19,039 Equity 2024: € 19,039 ▼ 10% vs 2023 (€ 21,091) Unfavourable step	€ 12,400 Equity 2025: € 12,400 ▼ 35% vs 2024 (€ 19,039) Unfavourable step	▼ 35%
Total debts	€ 181,443 Total debts 2022: € 181,443 First fiscal year in the series	€ 169,618 Total debts 2023: € 169,618 ▼ 7% vs 2022 (€ 181,443) Favourable step	€ 179,044 Total debts 2024: € 179,044 ▲ 6% vs 2023 (€ 169,618) Unfavourable step	€ 190,250 Total debts 2025: € 190,250 ▲ 6% vs 2024 (€ 179,044) Unfavourable step	▲ 6%
Cash	€ 179,484 Cash 2022: € 179,484 First fiscal year in the series	€ 95,191 Cash 2023: € 95,191 ▼ 47% vs 2022 (€ 179,484) Unfavourable step	€ 137,933 Cash 2024: € 137,933 ▲ 45% vs 2023 (€ 95,191) Favourable step	€ 148,915 Cash 2025: € 148,915 ▲ 8% vs 2024 (€ 137,933) Favourable step	▲ 8%
Retained profit	€ 10,866 Retained profit 2022: € 10,866 First fiscal year in the series	€ 8,691 Retained profit 2023: € 8,691 ▼ 20% vs 2022 (€ 10,866) Unfavourable step	€ 6,639 Retained profit 2024: € 6,639 ▼ 24% vs 2023 (€ 8,691) Unfavourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 6,639) Unfavourable step	▼ 100%
Dividend	€ 135,000 Dividend 2022: € 135,000 First fiscal year in the series	€ 121,955 Dividend 2023: € 121,955 ▼ 10% vs 2022 (€ 135,000) Unchanged	€ 135,000 Dividend 2024: € 135,000 ▲ 11% vs 2023 (€ 121,955) Unchanged	€ 163,266 Dividend 2025: € 163,266 ▲ 21% vs 2024 (€ 135,000) Unchanged	▲ 21%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 49,573 Bank debt 2023: € 49,573 Unchanged (€ 0) Unfavourable step	€ 39,546 Bank debt 2024: € 39,546 ▼ 20% vs 2023 (€ 49,573) Favourable step	€ 29,092 Bank debt 2025: € 29,092 ▼ 26% vs 2024 (€ 39,546) Favourable step	▼ 26%
Balance sheet total	€ 204,709 Balance sheet total 2022: € 204,709 First fiscal year in the series	€ 190,709 Balance sheet total 2023: € 190,709 ▼ 7% vs 2022 (€ 204,709) Unchanged	€ 198,083 Balance sheet total 2024: € 198,083 ▲ 4% vs 2023 (€ 190,709) Unchanged	€ 202,650 Balance sheet total 2025: € 202,650 ▲ 2% vs 2024 (€ 198,083) Unchanged	▲ 2%

Key figures of Dr. Patrick Braeckman, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to Dr. Patrick Braeckman?

What happened at Dr. Patrick Braeckman in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Feb 2, 2026 New annual accounts for financial year 2025: profit of € 156,627 (▲ 18% vs 2024). filed late Source: NBB ↗
Jul 11, 2005 New establishment in Ronse. KBO
2005 Patrick Braeckman became a director. NBB
Jul 11, 2005 Start of the company according to the CBE. KBO

In short

From € 135,633 profit in 2022 to € 156,627 profit in 2025.

Paid € 164,766 in corporate taxes since 2022.

Best year ever: 2025, with € 156,627 profit.

Paid out € 555,221 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Patrick Braeckman? We notify you, reason included.

Follow Dr. Patrick Braeckman

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Patrick Braeckman

Dr. Patrick Braeckman

Immonac

Behind Dr. Patrick Braeckman is Patrick Braeckman. Patrick Braeckman is also behind Immonac.

See the full network in the app

Directors

According to the 2025 annual accounts

Patrick Braeckman

Director

Also active at: Immonac

since 2005

Establishments

Establishment units

Physical locations of this company

Registered office

Tasscheweg 13

8800 Roeselare

2.302.442.082

Stefaan Modest Glorieuxlaan 55

9600 Ronse

Active since 11 July 2005

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0874.988.203
VAT number: BE 0874.988.203
Registered office: Tasscheweg 13, 8800 Roeselare
Names & denominations: Dr. Patrick Braeckman
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 11 July 2005
Peppol: Active · Active since 11 Mar 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗